학술논문

Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)
Document Type
Article
Source
In: Gynecologic Oncology. (Gynecologic Oncology, November 2023, 178:161-169)
Subject
Language
English
ISSN
10956859
00908258